Yang-Cheng Lee

Real-World Effectiveness of Sorafenib versus Lenvatinib Combined with PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma

Hsueh‐Chien Chiang, Yang-Cheng Lee, Ting‐Tsung Chang, Yih‐Jyh Lin et autres

Immune checkpoint inhibitors (ICIs) combined with multitarget tyrosine kinase inhibitors (MTKIs) exert a synergistic effect and are effective in unresectable hepatocellular carcinoma (uHCC). However, precise data regarding the real-world clinical applications of these combination therapies in uHCC are lacking. This study compared …

tw (code pays fourni par la source)

Bevacizumab and Atezolizumab for Unresectable Hepatocellular Carcinoma: Real-world Data in Taiwan-Tainan Medical Oncology Group H01 Trial

Yang-Cheng Lee, Wen‐Tsung Huang, Ming‐Yang Lee, Chao‐Jung Tsao et autres

BACKGROUND/AIM: The combination of bevacizumab and atezolizumab (Bev-Ate) has been established as a standard first-line systemic treatment option for unresectable hepatocellular carcinoma (HCC) since 2020. This study examined the outcomes of HCC patients who received the combination in southern Taiwan. PATIENTS AND …

tw (code pays fourni par la source)

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma

Hsin‐Yu Kuo, Meng‐Zhi Han, Chih‐Hsiang Liao, Yih‐Jyh Lin et autres

Purpose: Immune checkpoint inhibitors are effective therapies for advanced hepatocellular carcinoma (HCC); however, comparisons of the clinical efficacy and safety profile for these drugs are still scarce. Thus, the aims of this study were to investigate the differences in efficacy and safety …

tw (code pays fourni par la source)

Additional file 1 of Health inequality: a longitudinal study on geographic variations in lung cancer incidence and mortality in Taiwan

Jason C. Hsu, Yu‐Chi Tseng, Sheng‐Mao Chang, Yang-Cheng Lee et autres

Additional file 1.

tw (code pays fourni par la source)

Association between palliative care and end-of-Life care for patients with hematological malignancies

Jui‐Kun Chiang, Yang-Cheng Lee, Yee-Hsin Kao

To date, few studies have examined the end-of-life (EOL) care for patients with hematological malignancies (HMs). We evaluated the effects of palliative care on the quality of EOL care and health care costs for adult patients with HMs in the final month …

us, tw (code pays fourni par la source)

Traditional Chinese medicine is associated with a decreased risk of heart failure in breast cancer patients receiving doxorubicin treatment

Ching-Hui Huang, Hui-Ping Chang, Shou-Yi Su, Wen‐Kang Chen et autres

tw (code pays fourni par la source)

Trend analysis of end-of-life care between hospice and nonhospice groups of cancer patients in Taiwan for 2002–11

Jui‐Kun Chiang, Yang-Cheng Lee, Yee-Hsin Kao

The aim of the study is to examine the effect of hospice care on quality of end-of-life (EOL) care for patients with advanced cancer in Taiwan between 2002 and 2011.It is a population-based longitudinal study following National Health Insurance medical care claims …

il, tw, us (code pays fourni par la source)

FDG Uptake in Sacroiliac Joint Due to Osteitis Condensans Ilii Shown on PET/CT in a Patient With Breast Cancer

Yang-Cheng Lee, Kuan-Yung Chen, Jainn-Shiun Chiu, Chia‐Hung Kao et autres

A 56-year-old woman with breast cancer underwent FDG PET/CT at follow-up. The PET images showed increased FDG uptake along right sacroiliac joint. The coregistered CT images showed diffuse sclerosis around the sacroiliac joints, but no bony destruction, periarticular erosion, or joint space …

tw (code pays fourni par la source)